(VIANEWS) – RenaissanceRe Hold (RNR), Novo Nordisk A/S (NVO), Dorian LPG Ltd. (LPG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. RenaissanceRe Hold (RNR)
38.3% sales growth and 20.84% return on equity
RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S. multi-line reinsurance. The Casualty and Specialty segment writes various classes of products, such as directors and officers, medical malpractice, and professional indemnity; automobile and employer's liability, casualty clash, umbrella or excess casualty, workers' compensation, and general liability; financial and mortgage guaranty, political risk, surety, and trade credit; and accident and health, agriculture, aviation, cyber, energy, marine, satellite, and terrorism. The company distributes its products and services primarily through intermediaries. It also invests in and manages funds. RenaissanceRe Holdings Ltd. was founded in 1993 and is headquartered in Pembroke, Bermuda.
Earnings Per Share
As for profitability, RenaissanceRe Hold has a trailing twelve months EPS of $30.48.
PE Ratio
RenaissanceRe Hold has a trailing twelve months price to earnings ratio of 6.43. Meaning, the purchaser of the share is investing $6.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.84%.
Volume
Today’s last reported volume for RenaissanceRe Hold is 345619 which is 30.58% below its average volume of 497869.
Sales Growth
RenaissanceRe Hold’s sales growth is 16.9% for the ongoing quarter and 38.3% for the next.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Dec 13, 2023, the estimated forward annual dividend rate is 1.52 and the estimated forward annual dividend yield is 0.78%.
2. Novo Nordisk A/S (NVO)
26.8% sales growth and 88.77% return on equity
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Earnings Per Share
As for profitability, Novo Nordisk A/S has a trailing twelve months EPS of $2.48.
PE Ratio
Novo Nordisk A/S has a trailing twelve months price to earnings ratio of 41.71. Meaning, the purchaser of the share is investing $41.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 88.77%.
Moving Average
Novo Nordisk A/S’s value is above its 50-day moving average of $99.64 and way higher than its 200-day moving average of $88.07.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 50% and 29.7%, respectively.
3. Dorian LPG Ltd. (LPG)
14.8% sales growth and 29.22% return on equity
Dorian LPG Ltd., together with its subsidiaries, engages in the transportation of liquefied petroleum gas (LPG) through its LPG tankers worldwide. The company owns and operates very large gas carriers (VLGCs). As of March 31, 2020, its fleet consisted of twenty-four VLGCs. The company was founded in 2013 and is headquartered in Stamford, Connecticut.
Earnings Per Share
As for profitability, Dorian LPG Ltd. has a trailing twelve months EPS of $6.35.
PE Ratio
Dorian LPG Ltd. has a trailing twelve months price to earnings ratio of 7.04. Meaning, the purchaser of the share is investing $7.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.22%.
4. Saratoga Investment Corp New (SAR)
12.2% sales growth and 9.41% return on equity
Saratoga Investment Corp. is a business development company specializing in leveraged and management buyouts, acquisition financings, growth financings, recapitalization, debt refinancing, and transitional financing transactions at the lower end of middle market companies. It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, co-investments, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity. The firm prefers to invest in aerospace, automotive aftermarket and services, business products and services, consumer products and services, education, environmental services, industrial services, financial services, food and beverage, healthcare products and services, logistics, distribution, manufacturing, restaurants services, food services, software services, technology services, specialty chemical, media and telecommunications. It seeks to invest in the United States. The firm primarily invests $5 million to $50 million in companies having EBITDA of $2 million or greater and revenues of $8 million to $250 million. The firm prefer to take a majority stake. It invests through direct lending as well as participation in loan syndicates. The firm was formerly known as GSC Investment Corp. Saratoga Investment Corp. is based in New York, New York with an additional office in Florham Park, New Jersey.
Earnings Per Share
As for profitability, Saratoga Investment Corp New has a trailing twelve months EPS of $2.74.
PE Ratio
Saratoga Investment Corp New has a trailing twelve months price to earnings ratio of 9.32. Meaning, the purchaser of the share is investing $9.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.41%.
Moving Average
Saratoga Investment Corp New’s worth is higher than its 50-day moving average of $25.03 and under its 200-day moving average of $25.56.
Sales Growth
Saratoga Investment Corp New’s sales growth for the next quarter is 12.2%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 102% and a drop 38.3% for the next.
Volume
Today’s last reported volume for Saratoga Investment Corp New is 50342 which is 55.01% below its average volume of 111917.
5. Texas Roadhouse (TXRH)
12% sales growth and 28.45% return on equity
Texas Roadhouse, Inc., together with its subsidiaries, operates casual dining restaurants in the United States and internationally. The company operates and franchises Texas Roadhouse and Bubba's 33 restaurants. As of December 29, 2020, it operated 537 domestic restaurants and 97 franchise restaurants. Texas Roadhouse, Inc. was founded in 1993 and is based in Louisville, Kentucky.
Earnings Per Share
As for profitability, Texas Roadhouse has a trailing twelve months EPS of $4.35.
PE Ratio
Texas Roadhouse has a trailing twelve months price to earnings ratio of 28.11. Meaning, the purchaser of the share is investing $28.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.45%.
Moving Average
Texas Roadhouse’s worth is way above its 50-day moving average of $109.33 and way higher than its 200-day moving average of $107.57.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 4, 2023, the estimated forward annual dividend rate is 2.2 and the estimated forward annual dividend yield is 1.79%.
Sales Growth
Texas Roadhouse’s sales growth is 14.7% for the ongoing quarter and 12% for the next.
Volume
Today’s last reported volume for Texas Roadhouse is 325534 which is 64.8% below its average volume of 924885.
6. Constellation Brands (STZ)
8.1% sales growth and 15.88% return on equity
Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. The company provides beer primarily under the Corona Extra, Corona Premier, Corona Familiar, Corona Light, Corona Refresca, Corona Hard Seltzer, Modelo Especial, Modelo Negra, Modelo Chelada, Victoria, Vicky Chamoy, and Pacifico brands. It also offers wine under the Cook's California Champagne, Kim Crawford, Meiomi, Mount Veeder, Ruffino, SIMI, My Favorite Neighbor, Robert Mondavi Winery, Schrader, and The Prisoner Wine Company brands; and spirits under the Casa Noble, Copper & Kings, High West, Mi CAMPO, Nelson's Green Brier, and SVEDKA brands. It provides its products to wholesale distributors, retailers, on-premise locations, and state alcohol beverage control agencies. The company was founded in 1945 and is headquartered in Victor, New York.
Earnings Per Share
As for profitability, Constellation Brands has a trailing twelve months EPS of $8.51.
PE Ratio
Constellation Brands has a trailing twelve months price to earnings ratio of 28.41. Meaning, the purchaser of the share is investing $28.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.88%.
7. Gartner (IT)
6.4% sales growth and 370.99% return on equity
Gartner, Inc. operates as a research and advisory company in the United States, Canada, Europe, the Middle East, Africa, and internationally. It operates through three segments: Research, Conferences, and Consulting. The Research segment delivers its research primarily through a subscription service that include on-demand access to published research content, data and benchmarks, and direct access to a network of research experts. The Conferences segment offers business professionals in an organization the opportunity to learn, share, and network. The Consulting segment offers market research, custom analysis, and on-the-ground support services. This segment also offers actionable solutions for IT-related priorities, including IT cost optimization, digital transformation, and IT sourcing optimization. Gartner, Inc. was founded in 1979 and is headquartered in Stamford, Connecticut.
Earnings Per Share
As for profitability, Gartner has a trailing twelve months EPS of $11.64.
PE Ratio
Gartner has a trailing twelve months price to earnings ratio of 38.76. Meaning, the purchaser of the share is investing $38.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 370.99%.
8. The Joint Corp. (JYNT)
5.8% sales growth and 6.15% return on equity
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of January 27, 2021, the company operated approximately 550 locations in the United States. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Earnings Per Share
As for profitability, The Joint Corp. has a trailing twelve months EPS of $0.18.
PE Ratio
The Joint Corp. has a trailing twelve months price to earnings ratio of 52.72. Meaning, the purchaser of the share is investing $52.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.15%.
Sales Growth
The Joint Corp.’s sales growth is 4.6% for the current quarter and 5.8% for the next.
